Olema Pharmaceuticals (OLMA) Accumulated Depreciation (2020 - 2023)
Olema Pharmaceuticals (OLMA) reported Accumulated Depreciation of $698000.0 for Q3 2023, up 44.21% year-over-year from $484000.0 in Q3 2022, and down 6.18% quarter-over-quarter from $744000.0 in Q2 2023.
Olema Pharmaceuticals (OLMA) Accumulated Depreciation (2020 - 2023) Analysis & Trends
Olema Pharmaceuticals (OLMA) has 4 years of Accumulated Depreciation data on file, last reported at $698000.0 in Q3 2023.
- Accumulated Depreciation for Q3 2023 came in at $698000.0, up 44.21% year-over-year; the trailing twelve-month figure through Sep 2023 was $698000.0 (up 44.21% YoY), and the FY2022 annual result was $581000.0, up 159.38% from the prior year.
- Accumulated Depreciation retreated to $698000.0 in Q3 2023 per OLMA's latest filing, from $744000.0 in the prior quarter.
- Over five years, Accumulated Depreciation peaked at $744000.0 in Q2 2023 and troughed at $62000.0 in Q4 2020.
- A 4-year average of $374833.3 and a median of $350500.0 in 2022 frame the typical range for Accumulated Depreciation.
- The sharpest annual moves came in 2022 and 2023: Accumulated Depreciation jumped 340.0% in 2022, then surged 44.21% in 2023.
- A 4-year view of Accumulated Depreciation shows it stood at $62000.0 in 2020, then surged by 261.29% to $224000.0 in 2021, then surged by 159.38% to $581000.0 in 2022, then advanced by 20.14% to $698000.0 in 2023.
- Business Quant data shows OLMA's Accumulated Depreciation at $698000.0 in Q3 2023, $744000.0 in Q2 2023, and $681000.0 in Q1 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - |
| 10 | Olema Pharmaceuticals | 1.01 Bn | 1.01 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | 698,000.00 |
| Jun 30, 2023 | 744,000.00 |
| Mar 31, 2023 | 681,000.00 |
| Dec 31, 2022 | 581,000.00 |
| Sep 30, 2022 | 484,000.00 |
| Jun 30, 2022 | 393,000.00 |
| Mar 31, 2022 | 308,000.00 |
| Dec 31, 2021 | 224,000.00 |
| Sep 30, 2021 | 151,000.00 |
| Jun 30, 2021 | 102,000.00 |
| Mar 31, 2021 | 70,000.00 |
| Dec 31, 2020 | 62,000.00 |